Business Context and Reporting Period
This Form 8-K Current Report, filed on March 19, 2025, by Universal Health Services, Inc. (UHS), details the approval of executive compensation arrangements for the fiscal year ending December 31, 2025. The filing specifically addresses the 2025 Annual Incentive Bonus Performance Goals, the grant of Long-Term Incentive Stock-Based Compensation, and the execution of new employment agreements for the Chief Executive Officer and Executive Chairman.
Key Financial Metrics and Compensation Details
The filing does not report operational financial metrics such as revenue, profit, cash flow, or debt levels. Instead, it discloses specific compensation figures and equity grant values:
- Stock Price: The grant date market value of Class B Common Stock on March 19, 2025, was $178.08 per share.
- Discretionary Bonus: A cash bonus of $1.08 million was approved for Executive Chairman Alan B. Miller for the year ended December 31, 2024.
- 2025 Base Salaries:
- Marc D. Miller (CEO): $1,500,000 (a 6.7% increase from 2024).
- Alan B. Miller (Executive Chairman): $1,125,000 (a 4.0% increase from 2024).
- Target Bonus Percentages (2025):
- Marc D. Miller: 150% of base salary.
- Steve G. Filton (CFO): 100% of base salary.
- Edward H. Sim (EVP, Acute Care): 100% of base salary (split 25% corporate/75% divisional).
- Matthew J. Peterson (EVP, Behavioral Health): 100% of base salary (split 25% corporate/75% divisional).
- Equity Awards (RSUs and PBRSUs):
- Marc D. Miller: 28,077 Time-Based RSUs and 28,077 Performance-Based RSUs.
- Alan B. Miller: 14,213 Time-Based RSUs and 14,213 Performance-Based RSUs.
- Steve G. Filton: 6,879 Time-Based RSUs and 6,879 Performance-Based RSUs.
- Edward H. Sim: 6,431 Time-Based RSUs and 6,431 Performance-Based RSUs.
- Matthew J. Peterson: 5,651 Time-Based RSUs and 5,651 Performance-Based RSUs.
Material Changes Versus Prior Period
The primary material changes disclosed in this filing relate to executive compensation structures and employment terms:
- Employment Agreements: New employment agreements were executed on March 19, 2025, replacing prior agreements for both Marc D. Miller and Alan B. Miller. The new agreements are with UHS of Delaware, a wholly owned subsidiary, and are guaranteed by the parent company.
- Salary Increases: Both the CEO and Executive Chairman received base salary increases for 2025 compared to 2024.
- Contract Terms:
- Marc D. Miller's term is scheduled to end January 1, 2028, with automatic one-year renewals.
- Alan B. Miller's term is scheduled to end January 1, 2027, with automatic one-year renewals.
- Performance Metrics: The 2025 incentive plan utilizes adjusted net income per diluted share and return on capital as corporate criteria, and divisional pre-tax income (net of estimated cost of capital) for divisional leaders.
Guidance, Outlook, and Risks
Management Commentary and Outlook: The filing outlines the performance thresholds for executive compensation. Corporate performance targets are based on a specified range of adjusted net income per diluted share and return on capital. Divisional targets for Messrs. Sim and Peterson are based on projected aggregate pre-tax income for acute care and behavioral health segments. The filing does not provide specific numerical guidance for future revenue or earnings.
Risks and Contingencies:
- Severance and Acceleration: Both executive agreements include significant "change in control" or "without cause" termination provisions. If terminated without cause or due to a material breach by the company, executives are entitled to continued cash compensation, long-term equity, and accelerated vesting of awards for the remainder of the term.
- Disability and Death: Provisions exist for pro-rata bonuses and specific lump-sum payments (e.g., half of base salary for disability) in the event of termination due to disability or death.
- Release Conditions: The company may condition severance benefits on the execution of a general release.
Important Facts for Investor Verification
- Verify the specific numerical thresholds for "adjusted net income per diluted share" and "return on capital" referenced in the Proxy Statement to understand the difficulty of achieving target bonuses.
- Review the full text of the new employment agreements (Exhibits 10.1 and 10.2) to confirm the precise definitions of "cause," "disability," and "material change in duties."
- Assess the financial impact of the $1.08 million discretionary bonus paid to Alan B. Miller for 2024 and the increased 2025 base salaries on the company's compensation expense.
- Monitor the vesting schedule of the newly granted RSUs (four equal installments) and the three-year performance period for PBRSUs tied to adjusted EBITDA growth.